MTOR and colitis: Zhou et al. demonstrated that autophagic dysfunction is linked to intestinal inflammation, with mTOR inhibitors or autophagy activators significantly mitigating LPS-induced colitis in mice and the inflammatory response in intestinal epithelial cells [37].